Memorial Sloan Kettering Cancer Center-Main Campus — New York, New York

Memorial Sloan Kettering Cancer Center-Main Campus is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Memorial Sloan Kettering Cancer Center-Main Campus has participated in 2 clinical trials.

Therapeutic areas: Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Relay Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memorial Sloan Kettering Cancer Center-Main Campus?

Memorial Sloan Kettering Cancer Center-Main Campus has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memorial Sloan Kettering Cancer Center-Main Campus conducted?

Memorial Sloan Kettering Cancer Center-Main Campus has 2 clinical trials on record. Their work covers Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral.

Is Memorial Sloan Kettering Cancer Center-Main Campus accredited by Crixeo Health?

Memorial Sloan Kettering Cancer Center-Main Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Memorial Sloan Kettering Cancer Center-Main Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.